Lipocine expects trial data to support a 505(b)(2) new drug application submission for LPCN 1154 in 2026.

RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...

Patient choice in taking treatment is framed by the physiological and psychological impacts of the disease and also by the social and cultural structures in which the person is immersed. [68] Patient ...

TB remains the leading cause of death among people living with HIV. Uganda is a high TB-burden country, and HIV accelerates ...

TB patients with severe undernutrition have four to five times higher chance of mortality, necessitating early nutrition support ...

Maria Bambina Sr. Agustina Tudu, 69, is a Santal Indigenous from Dinajpur, a northern district of Bangladesh. Tudu took her ...

Now a museum, the Saranac Laboratory was established in 1894 and was the first in the United States dedicated to studying ...